CytomX Therapeutics, Inc. Total Shareholder Rtn Amt
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-04-30
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $266.25 DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $64.38 DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $96.88 DEF 14A · filed 2026-04-30 |